1. Home
  2. SIBN vs DLX Comparison

SIBN vs DLX Comparison

Compare SIBN & DLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • DLX
  • Stock Information
  • Founded
  • SIBN 2008
  • DLX 1915
  • Country
  • SIBN United States
  • DLX United States
  • Employees
  • SIBN N/A
  • DLX N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • DLX Advertising
  • Sector
  • SIBN Health Care
  • DLX Consumer Discretionary
  • Exchange
  • SIBN Nasdaq
  • DLX Nasdaq
  • Market Cap
  • SIBN 805.4M
  • DLX 655.1M
  • IPO Year
  • SIBN 2018
  • DLX N/A
  • Fundamental
  • Price
  • SIBN $16.39
  • DLX $14.76
  • Analyst Decision
  • SIBN Strong Buy
  • DLX Strong Buy
  • Analyst Count
  • SIBN 5
  • DLX 1
  • Target Price
  • SIBN $24.40
  • DLX $23.00
  • AVG Volume (30 Days)
  • SIBN 451.8K
  • DLX 370.3K
  • Earning Date
  • SIBN 08-04-2025
  • DLX 07-30-2025
  • Dividend Yield
  • SIBN N/A
  • DLX 8.19%
  • EPS Growth
  • SIBN N/A
  • DLX 61.76
  • EPS
  • SIBN N/A
  • DLX 1.24
  • Revenue
  • SIBN $176,601,000.00
  • DLX $2,123,277,000.00
  • Revenue This Year
  • SIBN $19.48
  • DLX $0.67
  • Revenue Next Year
  • SIBN $16.86
  • DLX $1.08
  • P/E Ratio
  • SIBN N/A
  • DLX $11.77
  • Revenue Growth
  • SIBN 22.60
  • DLX N/A
  • 52 Week Low
  • SIBN $11.70
  • DLX $13.61
  • 52 Week High
  • SIBN $20.05
  • DLX $24.87
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 36.27
  • DLX 47.48
  • Support Level
  • SIBN $17.35
  • DLX $14.71
  • Resistance Level
  • SIBN $19.24
  • DLX $15.15
  • Average True Range (ATR)
  • SIBN 0.61
  • DLX 0.44
  • MACD
  • SIBN -0.40
  • DLX 0.01
  • Stochastic Oscillator
  • SIBN 2.00
  • DLX 38.73

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About DLX Deluxe Corporation

Deluxe Corporation is principally a payments and data company. Its reportable segments are; Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services as well as financial institution profitability reporting and business incorporation services.

Share on Social Networks: